5,6-dihydro-11H-indolo[2,3-B]quinolin-11-ones as alk inhibitors
Abstract:
The present disclosure provides compounds represented by Formula (I), and the pharmaceutically acceptable salts and solvates thereof wherein R1a, R1b, R2a, R2b, R3, R4, R5, R6, R7, E and (B) are as defined as set forth in the specification. The present disclosure also provides compounds of Formula (I) for use to treat a condition or disorder responsive to inhibition of ALK such as cancer. and ®
Public/Granted literature
Information query
Patent Agency Ranking
0/0